Molecular genetics of inherited neuropathies

Clinical Neurology

Volumn 46, Issue 1, 2006, Pages 1-18

  Takashima, Hiroshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Charcot Marie Tooth disease; Dejerine Sottas disease; HMSN P; Spinocerebellar ataxia; SSBR

Indexed keywords

CYTOSKELETON PROTEIN; DNA TOPOISOMERASE; GAP JUNCTION PROTEIN; HEAT SHOCK PROTEIN; LAMIN A; MYELIN PROTEIN; NEUROFILAMENT PROTEIN; PERIPHERAL MYELIN PROTEIN 22; RAB7 PROTEIN; RNA; TRANSCRIPTION FACTOR SOX10;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CEREBELLAR ATAXIA; CHROMOSOME 3; DEMYELINATION; DIAPHRAGM PARALYSIS; FASCICULATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GLAUCOMA; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOLECULAR GENETICS; MUSCLE CRAMP; MUSCLE WEAKNESS; NERVE CONDUCTION; NONHUMAN; NONSENSE MUTATION; PERIPHERAL NERVE; REVIEW; SURAL NERVE; VOCAL CORD PARALYSIS; YEAST;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CHARCOT-MARIE-TOOTH DISEASE; DEMYELINATING DISEASES; GENES, RECESSIVE; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; HUMANS; LINKAGE (GENETICS); MEMBRANE PROTEINS; MUTATION; PERIPHERAL NERVES; PROTEINS;

EID: 33645781958     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Takashima H, Nakagawa M, Nakahara K, et al: A new-type of hereditary motor and sensory neuropathy linked to chromosome 3. Ann Neurol 1997; 41: 771-780
2. Takashima H, Nakagawa M, Kanzaki A, et al: Germline mosaicism of MPZ gene in Dejerine-Sottas syndrome (HMSN III) associated with hereditary stomatocytosis. Neuromuscul Disord 1999; 9: 232-238
3. Takashima H, Nakagawa M, Suehara M, et al: Gene for hereditary motor and sensory neuropathy (proximal dominant form) mapped to 3q13.1. Neuromuscul Disord 1999; 9: 368-371
4. Nakagawa M, Suehara M, Saito A, et al: A novel MPZ gene mutation in dominantly inherited neuropathy with focally folded myelin sheaths. Neurology 1999; 52: 1271-1275
5. Kiwaki T, Umehara F, Takashima H, et al: Hereditary motor and sensory neuropathy with myelin folding and juvenile onset glaucoma. Neurology 2000; 55: 392-397
6. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, et al: DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991; 66: 219-232
7. Reiter LT, Murakami T, Koeuth T, et al: A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 1996; 12: 288-297
8. Warner LE, Mancias P, Butler IJ, et al: Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998; 18: 382-384
9. Boerkoel CF, Takashima H, Stankiewicz P, et al: Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 2001; 68: 325-333
10. Takashima H, Boerkoel CF, De Jonghe P, et al: Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 2002; 51: 709-715
11. Boerkoel CF, Takashima H, John J, et al: Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 2002; 30: 215-220
12. Takashima H, Boerkoel CF, John J, et al: Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 2002; 32: 267-272
13. Boerkoel CF, Takashima H, Nakagawa M, et al: CMT4A: identification of a Hispanic GDAP1 founder mutation. Ann Neurol 2003; 53: 400-405
14. Hirano R, Takashima H, Umehara F, et al: SET binding factor 2 (SBF2) mutation causes CMT4B with juvenile onset glaucoma. Neurology 2004; 63: 577-580
15. Nakagawa M, Takashima H: [Molecular mechanisms of hereditary neuropathy: genotype-phenotype correlation]. Rinsho Byori 2003; 51: 536-543
16. Nakagawa M, Takashima H: [Update on hereditary neuropathy]. Rinsho Shinkeigaku 2004; 44: 991-994
17. Saifi GM, Szigeti K, Snipes GJ, et al: Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies. J Investig Med 2003; 51: 261-283
18. Evgrafov OV, Mersiyanova I, Irobi J, et al: Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 2004; 36: 602-606
19. Tang BS, Luo W, Xia K, et al: A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24. Hum Genet 2004; 114: 527-533
20. Zuchner S, Noureddine M, Kennerson M, et al: Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 2005; 37: 289-294
21. Irobi J, Van Impe K, Seeman P, et al: Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 2004; 36: 597-601
22. Nelis E, Berciano J, Verpoorten N, et al: Autosomal dominant axonal Charcot-Marie-Tooth disease type 2 (CMT2G) maps to chromosome 12q12-q13.3. J Med Genet 2004; 41: 193-197
23. Boerkoel CF, Takashima H, Lupski JR: The genetic convergence of Charcot-Marie-Tooth disease types 1 and 2 and the role of genetics in sporadic neuropathy. Curr Neurol Neurosci Rep 2002; 2: 70-77
24. Vallat JM, Grid D, Magdelaine C, et al: Autosomal recessive forms of Charcot-Marie-Tooth disease. Curr Neurol Neurosci Rep 2004; 4: 413-419
25. Jordanova A, De Jonghe P, Boerkoel CF, et al: Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 2003; 126: 590-597
26. Boerkoel CF, Takashima H, Garcia CA, et al: Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002; 51: 190-201
27. Hayasaka K, Himoro M, Sato W, et al: Charcot-Marie-Tooth neuropathy type IB is associated with mutations of the myelin P0 gene. Nat Genet 1993; 5: 31-34
28. Hayasaka K, Himoro M, Sawaishi Y, et al: De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat Genet 1993; 5: 266-268
29. Matsuyama W, Nakagawa M, Takashima H, et al: Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B. Acta Neuropathol (Berl) 2002; 103: 501-508
30. Nagarajan R, Svaren J, Le N, et al: EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 2001; 30: 355-368
31. Street VA, Bennett CL, Goldy JD, et al: Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003; 60: 22-26
32. Verhoeven K, De Jonghe P, Van de Putte T, et al: Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10. Am J Hum Genet 2003; 73: 926-932
33. Roa BB, Garcia CA, Pentao L, et al: Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nat Genet 1993; 5: 189-194
34. Baxter RV, Ben Othmane K, Rochelle JM, et al: Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 2002; 30: 21-22
35. Cuesta A, Pedrola L, Sevilla T, et al: The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 2002; 30: 22-25
36. Bolino A, Muglia M, Conforti FL, et al: Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 2000; 25: 17-19
37. Azzedine H, Bolino A, Taieb T, et al: Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet 2003; 72: 1141-1153
38. Senderek J, Bergmann C, Weber S, et al: Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 2003; 12: 349-356
39. Senderek J, Bergmann C, Stendel C, et al: Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet 2003; 73: 1106-1119
40. Kalaydjieva L, Gresham D, Gooding R, et al: N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 2000; 67: 47-58
41. Kijima K, Numakura C, Shirahata E, et al: Periaxin mutation causes early-onset but slow-progressive Charcot-Marie-Tooth disease. J Hum Genet 2004; 49: 376-379
42. Shimohata M, Hirahara K, Igarashi S, et al: [A pedigree of Charcot-Marie-Tooth disease type 4F (Periaxin mutation)]. Rinsho Shinkeigaku 2005; 45: 221-225
43. Zhao C, Takita J, Tanaka Y, et al: Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001; 105: 587-597
44. Zuchner S, Mersiyanova IV, Muglia M, et al: Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36: 449-451
45. Verhoeven K, De Jonghe P, Coen K, et al: Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72: 722-727
46. Antonellis A, Ellsworth RE, Sambuughin N, et al: Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003; 72: 1293-1299
47. Mersiyanova IV, Perepelov AV, Polyakov AV, et al: A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000; 67: 37-46
48. Tang BS, Zhao GH, Luo W, et al: Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet 2005; 116: 222-224
49. De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al: Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002; 70: 726-736
50. Bomont P, Cavalier L, Blondeau F, et al: The gene encoding gigaxonin. a new member of the cytoskeletal BTB/ kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 2000; 26: 370-374
51. Howard HC, Mount DB, Rochefort D, et al: The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet 2002; 32: 384-392
52. Hattori N, Yamamoto M, Yoshihara T, et al: Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 2003; 126: 134-151
53. Takashima H, Nakagawa M, Umehara F, et al: Gap junction protein beta 1 (GJB1) mutations and central nervous system symptoms in X-linked Charcot-Marie-Tooth disease. Acta Neurol Scand 2003; 107: 31-37
54. Nakagawa M, Takashima H, Umehara F, et al: Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence. J Neurol Sci 2001; 185: 31-37
55. Verhoeven K, Villanova M, Rossi A, et al: Localization of the gene for the intermediate form of Charcot-Marie-Tooth to chromosome 10q24.1-q25.1. Am J Hum Genet 2001; 69: 889-894
56. Jordanova A, Thomas FP, Guergueltcheva V, et al: Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35. Am J Hum Genet 2003; 73: 1423-1430
57. Senderek J, Bergmann C, Ramaekers VT, et al: Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. Brain 2003; 126: 642-649
58. Umehara F, Tate G, Itoh K, et al: A novel mutation of desert hedgehog in a patient with 46, XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet 2000; 67: 1302-1305
59. Nakagawa M, Takashima H, Suehara M, et al: Hereditary motor and sensory neuropathy with proximal dominant involvement: clinical, pathological, and genetic features. Ann N Y Acad Sci 1999; 883: 449-452
60. Kondo K, Tsubaki T, Sakamoto F: The Ryukyuan muscular atrophy. An obscure heritable neuromuscular disease found in the islands of southern Japan. J Neurol Sci 1970; 11: 359-382
61. Gillespie CS, Sherman DL, Fleetwood-Walker SM, et al: Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 2000; 26: 523-531
62. Guilbot A, Williams A, Ravise N, et al: A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 2001; 10: 415-421
63. Sherman DL, Fabrizi C, Gillespie CS, et al: Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 2001; 30: 677-687
64. Lawlor MW, Richards MP, De Vries GH, et al: Antibodies to L-periaxin in sera of patients with peripheral neuropathy produce experimental sensory nerve conduction deficits. J Neurochem 2002; 83: 592-600
65. Inoue K, Khajavi M, Ohyama T, et al: Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 2004; 36: 361-369
66. Robinson FL, Dixon JE: The phosphoinositide 3-phosphatase MTMR2 associates with MTMR13. a novel membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-tooth disease. J Biol Chem 2005; 280: 31699-31707
67. Interthal H, Chen HJ, Kehl-Fie TE, et al: SCAN1 mutant Tdp1 accumulates the enzyme-DNA intermediate and causes camptothecin hypersensitivity. Embo J 2005; 24: 2224-2233
68. El-Khamisy SF, Saifi GM, Weinfeld M, et al: Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 2005; 434: 108-113
69. Date H, Onodera O, Tanaka H, et al: Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet 2001; 29: 184-188
70. Moreira MC, Barbot C, Tachi N, et al: The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet 2001; 29: 189-193
71. Sano Y, Date H, Igarashi S, et al: Aprataxin, the causative protein for EAOH is a nuclear protein with a potential role as a DNA repair protein. Ann Neurol 2004; 55: 241-249
72. Date H, Igarashi S, Sano Y, et al: The FHA domain of aprataxin interacts with the C-terminal region of XRCC1. Biochem Biophys Res Commun 2004; 325: 1279-1285
73. Moreira MC, Klur S, Watanabe M, et al: Senataxin, the ortholog of a yeast RNA helicase is mutant in ataxia-ocular apraxia 2. Nat Genet 2004; 36: 225-227
74. Chen YZ, Bennett CL, Huynh HM, et al: DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004; 74: 1128-1135
75. Caldecott KW: DNA single-strand break repair and spinocerebellar ataxia. Cell 2003; 112: 7-10
76. Connelly JC, Leach DR: Repair of DNA covalently linked to protein. Mol Cell 2004; 13: 307-316
77. Paulson HL, Miller VM: Breaks in coordination: DNA repair in inherited ataxia. Neuron 2005; 46: 845-848
78. Passage E, Norreel JC, Noack-Fraissignes P, et al: Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 2004; 10: 396-401